Accord Healthcare, Inc. is recalling 4,028 vials of Atropine Sulfate Injection and Bivalirudin for Injection because the products may contain particulate matter identified as fiber. These sterile medications were distributed nationwide to clinical settings. The firm initiated the voluntary recall after discovering the fiber particles during a routine inspection, as sterile injectable drugs must be free of any foreign matter to ensure patient safety.
Injecting medication that contains fiber particles can cause local irritation, inflammation, or swelling. In more serious cases, the particles could travel through the bloodstream and cause blood vessel blockage or damage to vital organs. No incidents or injuries have been reported to date.
Recall #: D-0917-2023; Quantity: 2348 vials
Recall #: D-0918-2023; Quantity: 1680 vials
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.